Profile
Christina Cameron is currently Director-Investor Relations at Medicago, Inc., Vice President-Investor Relations at Antibe Therapeutics, Inc., and Investor Relations & Media Contact at Medicenna Therapeutics Corp.
from 2019 to present.
Formerly, Ms. Cameron was an Independent Director at Zero Candida Technologies, Inc. from 2024 to 2026.
Education includes an undergraduate degree from Wilfrid Laurier University.
Christina Cameron active positions
| Companies | Position | Start |
|---|---|---|
| ANTIBE THERAPEUTICS INC. | Investor Relations Contact | - |
| MEDICENNA THERAPEUTICS CORP. | Investor Relations Contact | 31/01/2019 |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Contact | - |
Former positions of Christina Cameron
| Companies | Position | End |
|---|
Training of Christina Cameron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Wilfrid Laurier University
Wilfrid Laurier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Antibe Therapeutics, Inc.
Antibe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops pain and inflammation drugs | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Christina Cameron
















